• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Recent Advances in the Study of 4-Bromo-6-methyl-3H-1,3-benzodiazole (CAS: 1126824-09-6) and Its Applications in Chemical Biology and Medicine

The compound 4-Bromo-6-methyl-3H-1,3-benzodiazole (CAS: 1126824-09-6) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications as a building block in drug discovery and development. This research briefing aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activities, and potential therapeutic applications.

Recent studies have highlighted the role of 4-Bromo-6-methyl-3H-1,3-benzodiazole as a key intermediate in the synthesis of heterocyclic compounds with promising pharmacological properties. Researchers have successfully utilized this compound to develop novel inhibitors targeting various enzymes, including kinases and proteases, which are implicated in diseases such as cancer and neurodegenerative disorders. The bromo and methyl functional groups on the benzodiazole ring provide unique reactivity, enabling diverse chemical modifications.

In a 2023 study published in the Journal of Medicinal Chemistry, scientists demonstrated the efficacy of derivatives of 4-Bromo-6-methyl-3H-1,3-benzodiazole as potent inhibitors of the PI3K/AKT/mTOR signaling pathway, a critical target in oncology. The study reported that these derivatives exhibited nanomolar inhibitory activity and showed promising selectivity profiles in preclinical models. The findings suggest that this compound could serve as a scaffold for developing next-generation anticancer agents.

Another area of interest is the application of 4-Bromo-6-methyl-3H-1,3-benzodiazole in the design of fluorescent probes for bioimaging. A recent publication in Chemical Communications detailed the synthesis of a benzodiazole-based probe capable of selectively detecting reactive oxygen species (ROS) in live cells. This innovation opens new avenues for studying oxidative stress-related diseases, such as cardiovascular disorders and aging.

From a synthetic chemistry perspective, advancements in the efficient preparation of 4-Bromo-6-methyl-3H-1,3-benzodiazole have been reported. A 2022 paper in Organic Letters described a streamlined, high-yield synthesis route using palladium-catalyzed cross-coupling reactions, which significantly reduces production costs and improves scalability for industrial applications.

Despite these promising developments, challenges remain in optimizing the pharmacokinetic properties of benzodiazole-derived compounds. Future research directions may include structure-activity relationship (SAR) studies to improve bioavailability and reduce off-target effects. Additionally, the exploration of 4-Bromo-6-methyl-3H-1,3-benzodiazole in combination therapies and drug delivery systems represents an exciting frontier in medicinal chemistry.

In conclusion, 4-Bromo-6-methyl-3H-1,3-benzodiazole (CAS: 1126824-09-6) continues to emerge as a valuable tool in chemical biology and drug discovery. Its multifaceted applications, ranging from kinase inhibitors to bioimaging probes, underscore its importance in advancing biomedical research. Ongoing studies are expected to further elucidate its potential and expand its utility in therapeutic development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)